SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Pharvaris Reports Third Quarter 2026 Financial Results and Provides Business Update

Deucrictibant IR NDA under review by the FDA with PDUFA date of April 23, 2027 Topline data from par

PHVS

Related stories